Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose crossover bioequivalence study of generic desvenlafaxine 50 mg ER vs Pristiq in healthy Thai volunteers (fasting)
TCTR20240322003Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of desvenlafaxine (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
desvenlafaxine
Beyond the preview
Go deeper on TCTR20240322003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240322003.